Optimal management of ocular complications in axial spondyloarthritis: rethinking subcutaneous infliximab

Journal Article Accepted manuscript Optimal management of ocular complications in axial spondyloarthritis: rethinking subcutaneous infliximab Get access Eleana Bolla, Eleana Bolla Department of Rheumatology, 417 Army Share Fund Hospital (NIMTS), Athens, Greece Corresponding author: Eleana Bolla, 417 Army Share Fund Hospital (NIMTS), Rheumatology Department, Monis Petraki 10-12, Athens 11521, Greece, Email address: [email protected] https://orcid.org/0000-0002-7424-5364 Search for other works by this author on: Oxford Academic PubMed Google Scholar George E Fragoulis, George E Fragoulis Joint Academic Rheumatology Program, First Department of Propaedeutic and Internal Medicine Clinic, "Laiko" hospital, Athens, Greece https://orcid.org/0000-0003-4932-7023 Search for other works by this author on: Oxford Academic PubMed Google Scholar Alexios Iliopoulos Alexios Iliopoulos Department of Rheumatology, 417 Army Share Fund Hospital (NIMTS), Athens, Greece https://orcid.org/0000-0001-7107-1664 Search for other works by this author on: Oxford Academic PubMed Google Scholar Rheumatology, keae457, https://doi.org/10.1093/rheumatology/keae457 Published: 21 August 2024 Article history Received: 23 July 2024 Revision received: 13 August 2024 Accepted: 16 August 2024 Published: 21 August 2024